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Summary A 38-year-old man with a ventriculoatrial shunt presented with non-
specifi c symptoms (headache, back pain, night sweats) and inconclusive 
laboratory results. He showed an extremely high titre of antibody to 
Staphylococcus epidermidis which proved diagnostic of shunt infection. 
This was confirmed on shunt removal and he was successfully treated. 
 
BACKGROUND 
Ventriculoatrial (VA) shunting has been superseded in popularity 
by the use of the peritoneal route (ventriculoperitoneal (VP)), mainly because 
of ease of insertion of the latter. However, a substantial number are still used, 
either as primary insertions or to replace a persistently failing VP shunt. 1 – 3 
In addition, a large but unknown number of patients with VA shunts remain in 
the community, usually without neurosurgical follow-up, 4 and may require 
medical attention at any time. VA shunt infections can be particularly difficult 
to diagnose because unlike VP shunt infections they often present 
long after shunt insertion with non-specific symptoms, and often to a specialty 
other than neurosurgery. Also, while VP shunt infection is often associated 
with distal obstruction, VA shunt infection does not usually compromise 
shunt function. Though Staphylococcus epidermidis is the most common 
cause of VA shunt infection it is also a universal skin commensal. Blood 
cultures are often negative or inconclusive and the significance of a growth of 
S epidermidis can be difficult to determine. Ventricular cerebrospinal 
fluid (CSF) aspirated from the shunt reservoir can also show no evidence of 
infection when only the shunt hardware is colonised, and there remains a 
diagnostic problem. 
Almost all VA shunt infections are contracted at the time of shunt insertion. S 
epidermidis is very adherent to shunt tubing, forming a biofilm inside the shunt 
catheter, 5 – 7 which periodically sheds into the bloodstream, repeatedly 
inoculating the patient. This causes a rising antibody titre to S epidermidis , 
which eventually leads to immune complex deposition and the problems that 
are associated with this, such as shunt nephritis. 8 If a VA shunt is infected for 
more than a year, immune complex disease can be the presenting problem, 
but it often manifests with non-specific or misleading symptoms such as 
vague joint or muscle pains, tiredness or skin rash. Here we present a patient 
with a VA shunt and non-specific symptoms and inconclusive laboratory 
results, where the diagnosis was eventually made with the assistance of 
serological testing. 
CASE PRESENTATION 
The patient, a 38-year-old man with a Dandy Walker cyst and shunted 
hydrocephalus, had required several shunt revisions for malfunction and for 
infection as a child, the last one before this episode being at the age of nine, 
since when he had had a VP shunt. He was well until the age of 35, when he 
presented with headaches and abdominal pain. He underwent several 
revisions over the next year, but he continued to have abdominal pain so his 
shunt was revised to a VA shunt. The procedure was straightforward. 
He was asymptomatic when reviewed 3 months postoperatively. 
However, 7 months from the time of insertion he presented with severe 
headaches which were managed symptomatically. His symptoms resolved 
and he remained well for several months. After a further 4 months he 
presented with headaches and night sweats, and he was investigated for a 
possible shunt infection. 
INVESTIGATIONS 
CT scan, shunt series and inflammatory markers were all unremarkable at this 
time. In view of this, and because his night sweats resolved, a shunt infection 
was thought unlikely. He was admitted one month later, 17 months after VA 
insertion, with a short history of increased headache, back pain and night 
sweats. He now had raised inflammatory markers (C reactive protein 73.8 
mg/l, erythrocyte sedimentation rate 33 mm/h), though white cell count (7.6 
x109/l), blood urea (5.6 mmol/l) and creatinine (70 μmol/l) remained normal. 
Renal function and serum complement levels were normal, excluding shunt 
nephritis. Blood cultures grew S epidermidis which was considered by the 
laboratory to be a contaminant. CSF obtained by lumbar puncture showed no 
growth but a raised protein level (949 mg/l). Despite this, the clinical suspicion 
of VA shunt infection was high but there was reluctant to explore his shunt 
without definite evidence of infection. Blood was taken for an anti S 
epidermidis titre (ASET) and he was started on intravenous antibiotics 
awaiting the result. The titre was >40 000 (normal adult range 160–640), 
supporting the clinical suspicion of shunt infection.  
TREATMENT 
He therefore proceeded to shunt removal and external ventricular drain 
insertion. Ventricular CSF taken perioperatively showed Gram positive cocci 
on microscopy but no growth on culture. However, the shunt hardware 
grew S epidermidis , confi rming shunt infection. The patient was treated with 
a course of intravenous antibiotics, following which a new shunt was inserted. 
VA shunting was attempted but was unsuccessful so a ventriculo-pleural 
shunt was inserted instead. 
OUTCOME AND FOLLOW-UP 
He was discharged the following week and 1 year later 
remained well. 
DISCUSSION 
The ASET test, 5 9 available for almost four decades but not widely used, 
detects antibodies to S epidermidis that are formed as a result of inoculation 
from the distal catheter of the colonised VA shunt. The technology is simple, 
involving agglutination in microtitre trays. Serum ASET levels rise with age in 
a predictable manner, and normal ranges have been established. 10 The titre 
is usually <160 in children under 3 years of age. In adults, the normal range is 
160–640. Titres in infected cases often rise to 2560–40 000, providing clear 
diagnostic discrimination. In some cases, a rise in titre is more useful than the 
actual value itself. 
Our case describes a typical course of a patient with VA shunt infection, and 
highlights the difficulties in obtaining a definite diagnosis of infection. The 
patient initially presented with non-specific symptoms 7 months after shunt 
insertion. These symptoms resolved without treatment, but recurred at 12-
months from shunt insertion. Again, these symptoms greatly improved without 
treatment. The possibility of shunt infection was considered, but ruled out 
because the symptoms resolved without intervention. However, 17 months 
after shunt insertion the patient deteriorated. At this point, positive blood 
cultures were dismissed as contaminated and lumbar CSF cultures were 
negative. Only when a greatly elevated ASET result of >40,000 was obtained 
was it felt that there was suffi cient evidence of infection to warrant shunt 
removal. Infection was confirmed when S epidermidis was grown from the 
shunt hardware following removal. The patient recovered fully after shunt 
removal and antibiotics. In this case, the diagnosis was established and the 
infection treated before the patient developed immune complex disease, 
which occurs after prolonged hyperimmunisation. 8 Immune complex 
diseases occur as a late complication of VA shunt infection. However, patients 
who develop immune complex disease may present with a wide variety 
of non-specific symptoms, including rash, cough, joint pains, anaemia or 
haematuria. 11 This presentation can result in a delay in diagnosis, partly 
because patients are often referred to the wrong specialty to investigate one 
of these symptoms. A positive ASET test can help establish the diagnosis 
long before immune complex disease occurs. 10 
The ASET test can also be used as a screening tool for VA shunt infection. If 
the test is performed at the time of shunt insertion, this will establish a 
baseline level. If future tests show the level to have risen, this is indicative of 
shunt infection and prompt intervention can be carried out. 
In summary, diagnosis of VA shunt infection was typically difficult in our 
patient but was aided by the ASET 
test, allowing treatment of the shunt infection and precluding development of 
immune complex disease. The ASET test is a useful diagnostic tool when VA 
shunt infection is suspected, and can also be used for screening and early 
detection of shunt infection. 
Learning points 
▶ People with VA shunts still present with complications, sometimes years 
after shunting. 
▶ Clinical features of VA shunt infection can be nonspecific and misleading. 
▶ A high level of suspicion of shunt infection is essential. 
▶ The ASET test can aid diagnosis. 
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